Current Pain and Headache Reports最新文献

{"title":"An Updated Review of Utilization Patterns of Sacroiliac Joint Interventions in the Fee-for-service (ffs) Medicare Population from 2000 to 2022.","authors":"Laxmaiah Manchikanti, Vidyasagar Pampati, Alan D Kaye, Alaa Abd-Elsayed, Sahar Shekoohi, Mahendra R Sanapati, Amol Soin, Joshua A Hirsch","doi":"10.1007/s11916-026-01468-6","DOIUrl":"https://doi.org/10.1007/s11916-026-01468-6","url":null,"abstract":"","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":"30 1","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ultrasound Guided Radiofrequency Ablation of Suprascapular Nerve for Shoulder Pain: A Novel Technique Description.","authors":"Alaa Abd-Elsayed, Muhammed Zahid Şahin, Nina Hashimoto","doi":"10.1007/s11916-026-01469-5","DOIUrl":"https://doi.org/10.1007/s11916-026-01469-5","url":null,"abstract":"","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":"30 1","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147461063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Beyond the Procedure: Non-Clinical Complaints and Gender Disparity Dominate One-Star Yelp Reviews of Pain Physicians.","authors":"Andrew Owens, Jaden Poulter, Blaze Borowski, Sarang Koushik, Omar Viswanath, Matthew Smith, Paul Kang, Brian Wilhelmi","doi":"10.1007/s11916-026-01471-x","DOIUrl":"10.1007/s11916-026-01471-x","url":null,"abstract":"","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":"30 1","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12979255/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147437178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy of Erector Spinae Plane Block for Postoperative Pain Management in Breast Surgeries: A Systematic Review and Meta-analysis.","authors":"Shahab Ahmadzadeh, Harrison D Cooper, Taha Asif, Neel R Patel, Bradley Dorius, Matthew M Colontonio, Sahar Shekoohi, Alan D Kaye","doi":"10.1007/s11916-026-01467-7","DOIUrl":"https://doi.org/10.1007/s11916-026-01467-7","url":null,"abstract":"","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":"30 1","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147285808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Integrating Pain Prehabilitation into Surgical Pathways: Current Modalities, Outcomes, and Research Gaps.","authors":"Eric A Sosa, Anabel Henick, Dhanesh D Binda, Crystal Joseph, Stanley Kim, Dave Mathew, Singh Nair, Jinu Kim, David C Adams, Karina Gritsenko, Alan D Kaye, Ugur Yener, Hatice Begum Ciftci, Sayed E Wahezi, Naum Shaparin","doi":"10.1007/s11916-025-01464-2","DOIUrl":"10.1007/s11916-025-01464-2","url":null,"abstract":"","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":"30 1","pages":"30"},"PeriodicalIF":3.5,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12883514/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146144558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perioperative Management of Patients on Buprenorphine.","authors":"Nalini Vadivelu, Nicholas Mydlo, Christopher Dextras, Jessica Ng, Matthew Silverman, Gopal Kodumudi, Sean Chowdhari, Roberta Hines, Donna-Ann Thomas, Thomas Hickey","doi":"10.1007/s11916-025-01432-w","DOIUrl":"https://doi.org/10.1007/s11916-025-01432-w","url":null,"abstract":"<p><strong>Purpose of the review: </strong>Our review discusses the pharmacologic profile of buprenorphine, then dives into the current literature regarding buprenorphine's use to treat chronic pain, opioid use disorder, and acute postoperative pain. We aim to focus on how that literature may influence the perioperative management of patients on buprenorphine and prompt reconsideration of buprenorphine as a frontline opioid analgesic.</p><p><strong>Recent findings: </strong>Buprenorphine has been used effectively for both acute and chronic pain management, for the treatment of opioid withdrawal, and for the treatment of opioid use disorder due to its unique pharmacological profile. Historically, there has been controversy over the best practice recommendations for buprenorphine use in the perioperative setting, though the data now overwhelmingly refutes the full discontinuation of buprenorphine preoperatively. It has also been seen in recent times that buprenorphine is at least as effective as usual care opioids for acute pain management, with important safety advantages. Expanding our analgesic toolkit to more thoroughly understand the unique mechanism of action and properties of buprenorphine is paramount in our treatment of perioperative pain in both opioid-naïve and opioid-tolerant patients.</p>","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":"30 1","pages":"29"},"PeriodicalIF":3.5,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pivotal Factors for Minimizing the Risks of Therapeutic Failure in Trigeminal Neuralgia and Hemifacial Spasm.","authors":"Alexandra Mihaela Pătrășcan, Felix Mircea Brehar, Radu Mircea Gorgan","doi":"10.1007/s11916-025-01449-1","DOIUrl":"https://doi.org/10.1007/s11916-025-01449-1","url":null,"abstract":"<p><strong>Purpose of review: </strong>Despite the scarce literature regarding the matter, this current article identifies the most important factors that lead to the best outcomes in the therapeutic approach of trigeminal neuralgia and hemifacial spasm. However, notwithstanding the central focus lies on the neurosurgical perspective, the authors also integrate insights from adjacent medical specialties. Thus, the main objective of this comprehensive narrative review is to enhance understanding of the factors that can dramatically influence the course of these conditions.</p><p><strong>Recent findings: </strong>This article provides a state-of-the-art perspective regarding the therapeutic management of trigeminal neuralgia and hemifacial spasm. Preoperative diagnosis has the first pivotal role in managing this condition, and 3D multimodal image fusion based on Time-Of-Flight Magnetic Resonance Angiography (TOF MRA) with high-resolution T2-weighted imaging has been proven to be the most effective and accurate method. Focusing on the correct therapeutic approach is the second pivotal factor, given that the therapeutic options comprise various approaches ranging from oral medication to neurosurgical microvascular decompression. It has been concluded that microvascular decompression remains the most effective treatment for drug-resistant trigeminal neuralgia and hemifacial spasm. Pain freedom is achieved in around 76-84% of patients, and long-term durability remains substantial, with 64-73% still pain-free at ten years, particularly when the compression is arterial rather than venous. The endoscopic approaches demonstrated efficacy in selected cases, while combined procedures such as MVD with partial sensory rhizotomy may increase numbness without improving long-term results. Systematic reviews concluded that radiosurgery and percutaneous procedures can provide pain relief in many patients, but with less durable outcomes. Altogether, these findings support MVD as the cornerstone surgical therapy while underlining the importance of careful patient selection and modern adjuncts to maximize success. When the neurosurgical intervention represents the treatment option for trigeminal neuralgia or hemifacial spasm, several pivotal factors must be taken into account in order to provide the best clinical results with minimal to no complications.</p>","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":"30 1","pages":"27"},"PeriodicalIF":3.5,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perioperative Pain Management in Non-Operating Room Anesthesia (NORA) Settings.","authors":"Nalini Vadivelu, Nicholas Mydlo, Isabella Rosales, Gopal Kodumudi, Shilpa Rao, Nishita Lockwood, Kenneth W Hung, Thiruvengadam Muniraj","doi":"10.1007/s11916-025-01440-w","DOIUrl":"https://doi.org/10.1007/s11916-025-01440-w","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this review is to present an updated overview of the literature concerning the safe and effective management of perioperative pain in NORA settings. The increasing demand for minimally invasive procedures, driven by advancements in technology, has led to the growing utilization of non-operating room anesthesia (NORA) across multiple medical disciplines.</p><p><strong>Recent findings: </strong>Despite the growing utilization, there is a notable dearth of literature regarding the outcomes of NORA cases, particularly regarding pain management. NORA environments, such as bronchoscopy suites, magnetic resonance imaging (MRI) facilities, interventional cardiology suites, and gastrointestinal (GI) endoscopic units managing conditions like masses, cancers, and bleeding, present distinct challenges for effective pain control. Anesthesiology providers must exhibit adept familiarity and attentiveness, and be vigilant and prepared for diverse NORA settings, some of which may suffer from understaffing, inadequate infrastructure, or remote accessibility, potentially compromising patient outcomes. Further investigation into pain management strategies for NORA patients is imperative. The adaptation and progression of pain services within the dynamic healthcare landscape of NORA, characterized by continual evolution and shifting paradigms, are essential to meet the evolving demands of patient care effectively.</p>","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":"30 1","pages":"28"},"PeriodicalIF":3.5,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146127313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Management of Myogenous Temporomandibular Disorders with Botulinum Toxin: A Narrative Review and Management Recommendations.","authors":"Paul G Mathew, Marcela Romero-Reyes, Amrittej S Virk, Salvador L Manrriquez, Robert A Duarte, Antonia Teruel, Robert L Merrill, Carrie E Robertson, Donald Tanenbaum, Rich Cohen","doi":"10.1007/s11916-025-01463-3","DOIUrl":"https://doi.org/10.1007/s11916-025-01463-3","url":null,"abstract":"","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":"30 1","pages":"26"},"PeriodicalIF":3.5,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146121017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy and Safety of Melatonin in Migraine Prophylaxis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.","authors":"Moaz Elsayed Abouelmagd, Mohamed A Aldemerdash, Abdallah Ahmad Khatatbeh, Ahmed S A Osman, Abdallah Abbas, Salma Allam, Esraa M AlEdani, Ahmed Aldemerdash, Teshamae S Monteith","doi":"10.1007/s11916-025-01461-5","DOIUrl":"10.1007/s11916-025-01461-5","url":null,"abstract":"<p><strong>Background: </strong>Migraine is a chronic, disabling brain disorder. Melatonin, a circadian regulator with anti-inflammatory and antinociceptive actions, has been proposed for migraine prevention. We evaluated the efficacy and safety of melatonin for prophylaxis.</p><p><strong>Methods: </strong>We systematically searched PubMed, Cochrane, Scopus, Embase, and Web of Science (September 29, 2024) for randomised controlled trials (RCTs) comparing melatonin with placebo or other active drugs. Outcomes were analysed as change from baseline to last follow-up using mean differences (MD) or risk ratios (RR) with 95% confidence intervals (CI).</p><p><strong>Results: </strong>Nine RCTs (n = 788) were included. Versus placebo, melatonin reduced attack duration (MD -4.98 h; 95% CI -9.30 to -0.67; p = 0.02), headache days (MD -1.54 days; 95% CI -2.50 to -0.58; p < 0.01), headache severity (MD -2.08; 95% CI -2.91 to -1.26; p < 0.01), and analgesic use (MD -1.38; 95% CI -2.41 to -0.36; p < 0.01). Melatonin also increased the response rate (≥ 50% reduction in monthly headache frequency) (RR 1.38; 95% CI 1.11-1.70; p < 0.01) and improved sleep quality (PSQI: MD -1.64; 95% CI -2.85 to -0.42; p = 0.008) and disability (MIDAS: SMD - 4.07; 95% CI -5.45 to -2.69; p < 0.001). Compared with amitriptyline, melatonin was generally less effective for attack duration and severity, with no consistent advantage on analgesic use or response; however, melatonin showed a more favourable tolerability profile, including lower risk of sleepiness (RR 0.49; 95% CI 0.28-0.87; p = 0.01).</p><p><strong>Conclusions: </strong>Melatonin demonstrates benefits over placebo for reducing migraine burden and improving patient-reported outcomes, with a favourable safety profile. While amitriptyline remains more potent for several efficacy endpoints, melatonin represents a reasonable preventive option, particularly as an adjunct during titration of first-line agents. Further head-to-head trials with standardised dosing and longer follow-up are warranted.</p>","PeriodicalId":50602,"journal":{"name":"Current Pain and Headache Reports","volume":"30 1","pages":"25"},"PeriodicalIF":3.5,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12864225/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146108515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}